ICU Medical Inc ICUI Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Sousa Ben

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-1,299

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Sousa Ben

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-463

Price:

$98.08
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Sousa Ben

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

1,299

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Bonnell Brian Michael

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-3,247

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Bonnell Brian Michael

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-1,780

Price:

$98.08
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Bonnell Brian Michael

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

3,247

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Voigtlander Christian B.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-3,247

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Voigtlander Christian B.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-1,780

Price:

$98.08
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Voigtlander Christian B.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

3,247

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Woolson Daniel

Ownership Type:

Direct Ownership

Securities:

Performance Shares

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-2,923

Price:

--

Filings by filing date

Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Sousa Ben

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-1,299

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Sousa Ben

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-463

Price:

$98.08
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Sousa Ben

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

1,299

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Bonnell Brian Michael

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-3,247

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Bonnell Brian Michael

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-1,780

Price:

$98.08
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Bonnell Brian Michael

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

3,247

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Voigtlander Christian B.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-3,247

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Voigtlander Christian B.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-1,780

Price:

$98.08
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Voigtlander Christian B.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

3,247

Price:

--
Mar 15, 2024 (filed on Mar 18, 2024)

Insider Name:

Woolson Daniel

Ownership Type:

Direct Ownership

Securities:

Performance Shares

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-2,923

Price:

--

News

Biz Brief

Sector: Healthcare	Industry: Medical Equipment, Supplies & Distribution

See Regulatory Filings on SEC

Company Contact

Address:	951 Calle Amanecer SAN CLEMENTE CA 92673
Tel:	1-646-2771254
Website:	https://www.icumed.com
IR:	See website

Key People

Vivek Jain Chairman of the Board, Chief Executive Officer	Brian Michael Bonnell Chief Financial Officer, Treasurer	Christian B. Voigtlander Chief Operating Officer
Virginia Sanzone Corporate Vice President, General Counsel, Secretary	Daniel Woolson Corporate Vice President, General Manager - Infusion Systems

Business Overview

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.

Financial Overview

For the fiscal year ended 31 December 2023, ICU Medical Inc revenues decreased 1% to $2.26B. Net loss decreased 60% to $29.7M. Revenues reflect Vital Care segment decrease of 4% to $661M, Consumables segment decrease of 1% to $969.1M, United States segment decrease of 1% to $1.44B, APAC segment decrease of 6% to $241.7M. Lower net loss reflects Restructuring Charges/Provisions decrease of 42% to $41.3M (expense).

Employees:	14,000 as of Dec 31, 2023

Reporting Currency:	U.S. Dollars
Enterprise value:	$3,738M as of Dec 31, 2023
Annual revenue (TTM):	$2,259M as of Dec 31, 2023
EBITDA (TTM):	$293.92M as of Dec 31, 2023
Net annual income (TTM):	-$29.66M as of Dec 31, 2023
Free cash flow (TTM):	$72.53M as of Dec 31, 2023
Net Debt Last Fiscal Year:	$1,377M as of Dec 31, 2023
Shares outstanding:	24,365,082 as of Mar 19, 2024
Index Membership:	S&P 600 Small Cap
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization